2003 Marketing Therapies Vaccine 
The Pharma Data
MARCH 26, 2021
The CHMP opinion is one of the final steps in the marketing authorisation procedure prior to approval by the European Commission. The adverse reactions observed in BLISS-LN were consistent with the known safety profile of Benlysta administered intravenously plus standard therapy in patients with SLE. About the BLISS-LN study.
The Pharma Data
MAY 5, 2021
GlaxoSmithKline plc (GSK) today announced the European Commission has approved the expanded use of intravenous and subcutaneous BENLYSTA (belimumab) in combination with background immunosuppressive therapies for the treatment of adult patients with active lupus nephritis (LN) in Europe, in addition to systemic lupus erythematosus (SLE).
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
JULY 22, 2021
We believe patients, family members and physicians deserve the facts about the therapy and the process by which it was approved so they may make informed decisions. We believe that this will be further established as we collect more data from the ongoing EMBARK study and the post-marketing confirmatory trial.
Drug Target Review
NOVEMBER 30, 2023
On my return to Europe, I took a position at Nestlé as Head of the Research Centre, where I led the scientific development of several highly innovative health promoting food products from laboratory to market. Then I was approached to co-found AC Immune in 2003. COVID-19 has shown the revolutionary impact of vaccines.
The Pharma Data
FEBRUARY 25, 2021
FDA ACCEPTS FOR PRIORITY REVIEW PFIZER’S APPLICATION FOR TICOVAC (TICK-BORNE ENCEPHALITIS VACCINE). If approved, the vaccine may help reduce the risk of TBE for people traveling to endemic areas, potentially including military personnel serving in these locations. 1,2 If approved, TicoVac would be the first vaccine in the U.S.
The Pharma Data
APRIL 25, 2021
In contrast to other options for RSV under development, such as maternal vaccines, nirsevimab was designed to be administered at birth to infants born during the RSV season or at the season’s start for infants born prior to the season. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering.
The Pharma Data
MAY 13, 2021
Clients who get results will rave about your skills and nothing beats word of mouth marketing. Nutritional Therapy Practitioner. 2003 ACE Personal Trainer of the Year. ve built a six figure business by providing great service to my clients. This course will help you do that. Curb Ivanic, MS, CSCS. Jeff Salzenstein. Stephen Holt.
Expert insights. Personalized for you.
52 
Let's personalize your content